Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
The HardyChrom SS, from Hardy Diagnostics, is a selective chromogenic medium recommended for use as a primary screening medium for isolating and differentiating Salmonella and Shigella spp from stool cultures.
Sarstedt collection products for arterial and capillary blood gas determinations, consisting of 1-mL and 2-mL plastic blood gas syringes, contain a fine dispersion of calcium-balanced heparin, resulting in a large surface area for good solubility and quick mixing.
Dualsystems Biotech’s DualMembrane system detects novel interaction partners for membrane proteins and can be used to detect pairwise protein interactions, identify novel protein interactions by cDNA library screening, investigate ternary complexes, and map interaction domains. The system is available as a kit or custom screening service.
Bio SB now offers HRP Green, a vibrant chromogen to help clinical and research laboratories detect IHC markers on paraffin-embedded tissues. HRP Green comes in a two-part buffer and chromogen format that is compatible with all Bio SB polymer and biotin HRP-based detection systems. HRP Green requires a five-minute incubation period, can be counterstained with Nuclear Fast Red or hematoxylin, and is xylene (PermaMounter) compatible.
August 2013—Vector Laboratories now offers glycoprotein eluting solutions and neoglycoproteins. Five glycoprotein eluting solutions have been generated to complement the company’s range of agarose-bound lectins. These solutions maximize the yield of eluted glycoproteins from the beads and preserve lectin activity for repeat use.
Hamilton Robotics has a new module for its Microlab Star workstation that automates enzyme-linked immunoabsorbant assays (ELISAs). The ELISA StarLet module integrates precision liquid handling instrumentation with multiple devices and sophisticated software.
Leica Biosystems, in partnership with Indica Labs, has launched the HALO next-generation image-analysis software. The HALO platform is fast, scalable, and user-friendly and is for Aperio ePathology image analysis.
Beckman Coulter’s Microfuge 20 and 20R microcentrifuges are designed to meet the specific requirements of a range of research applications and are easy to use. Paired with Microfuge series rotors, the microcentrifuges provide flexibility and reliable, precise performance while occupying a small footprint.
Ventana Medical Systems has signed a worldwide agreement with health care imaging expert Barco to provide Barco’s diagnostic and clinical review display systems for use with Ventana’s Virtuoso image and workflow management system.
Health Canada has approved Life Technologies’ Applied Biosystems 3500 Dx/3500xL Dx genetic analyzers CS2 for diagnostic use. The Applied Biosystems 3500 Dx series genetic analyzers deliver high-quality performance, high throughput, and increased productivity for clinical laboratories. The 3500xL Dx is an automated 24-capillary-based Sanger sequencer; the 3500 Dx is an eight-capillary instrument.
